Format

Send to

Choose Destination
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1082-1089. doi: 10.1097/MEG.0000000000001149.

Automated low-flow ascites pump in a real-world setting: complications and outcomes.

Author information

1
Department of Gastroenterology, Hepatology and Endocrinology.
2
German Center for Infection Research (DZIF), Partner-Site Hannover Braunschweig, Hannover, Germany.
3
Clinic for General, Abdominal and Transplant Surgery.
4
Institute for Diagnostic and Interventional Radiology, Medical School Hannover.

Abstract

BACKGROUND AND AIMS:

The aim of this study was to investigate the Alfapump, an automated low-flow pump system for the treatment of refractory ascites (RA) as an alternative for repeated large-volume paracentesis in patients with contraindication for placement of a transjugular intrahepatic portosystemic shunt (TIPS) or liver transplantation.

MATERIALS AND METHODS:

In 21 consecutive patients with RA and contraindication for a placement of a TIPS, the Alfapump was implanted at Hannover Medical School between December 2012 and May 2016. Repeated laboratory, clinical, and microbiology data were collected and analyzed to assess the outcome of patients with an Alfapump. Half of the patients received a modified peritoneal catheter.

RESULTS:

Twenty-one patients with RA in end-stage liver disease and with a contraindication to TIPS placement received the Alfapump. Diuretic dosages were significantly reduced, and the number of paracentesis declined from 2.3±2.7 to 0 per week. Using the Alfapump, kidney function and serum sodium remained stable. Likewise, serum albumin remained stable in the absence of albumin infusions. Thirty-three complications (dislocation and/or blockade of the catheter, infection, pump dysfunction) related to the Alfapump were observed in 15 of 21 patients (71.4%), and 21 surgical interventions were needed in 15 patients (71.4%, 1-3 interventions per patient). A new peritoneal catheter system could significantly reduce blockage of the peritoneal catheter.

CONCLUSION:

The Alfapump is an effective treatment in patients with RA. However, a high rate of complications were observed, which could be reduced with a modified peritoneal catheter.

PMID:
29738325
DOI:
10.1097/MEG.0000000000001149
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center